Baird's CMC | Sexual and Reproductive Health

Sexual and Reproductive Health

Tel: +44 (0) 1495 200096
Email: team@bairdscmc.com

  • E-mail
  • LinkedIn
  • Twitter
Menu
  • Baird’s CMC Home
  • SRH Home
  • Why Us
    • Why work with Baird’s CMC in Sexual and Reproductive Health?
    • Affordable Pricing
    • Our Clients
    • Global database of SRH civil society organizations
    • Close
  • What we do
    • Qualitative Research
    • Policy Research & Analysis
    • Stakeholder Mapping
    • Assessing Opportunities & Demand Forecasting
    • Developing Organisational Strategy
    • Communications Strategy
    • Product Launches
    • Policy Communication
    • Government Relations
    • Issues Management
    • Scientific Communications
    • Public Relations
    • Close
  • Expertise
    • Hepatitis C
    • HIV / AIDS
    • Vaccines
    • Family Planning
    • Close
  • Our Team
    • Eric Brown, San Francisco, USA
    • Mark Chataway, Wales, UK
    • Lenore Cooney, New York, USA
    • Gerard Cunningham, Pennsylvania, USA
    • Paul Dillon, Dublin, Ireland
    • Marta Dourado, São Paulo, Brazil
    • Martina Dörmann, Berlin, Germany
    • Dirk van Eeden, Chicago, USA
    • Aman Gupta, New Delhi, India
    • Peter Impey, London, UK
    • Angelle B. Kwemo, USA
    • Simba Makoni, Harare, Zimbabwe
    • Terry Mandel, San Francisco, California, USA
    • Matshidiso Masire, Botswana
    • Valeria McFarren Piper, Charlottesville, USA
    • Hugh McKinney, London, UK
    • Dr. Ken Rabin, Warsaw, Poland
    • James Snodgrass, London, UK
    • Paul Tanner, London UK
    • Hema Viswanathan, Mumbai, India
    • Mina Volovitch, Paris, France
    • Chris Ward, Ontario, Canada
    • Marion Zibelli, Barcelona, Spain
    • Close
  • Case Studies
  • Blog
  • Get in Touch

Transforming the lives of Hepatitis C patients

How new breakthrough drugs are priced always creates heated debate. Gilead’s new breakthrough drug Sovaldi for hepatitis C was no exception. Here Baird’s CMC Associates at Ward Health, describe the issues and evidence surrounding the introduction of … [Read more...]

Filed Under: Hepatitis C Tagged With: Hepatitis C, Innovation, Market Access

Contact Us

    Your Name (required)

    Your Email (required)

    Subject

    Your Message

    Please enter the letters below and press Send
    captcha

    Latest Blog Posts

    India’s abortion law: time for change?

    Why we care: Champions for reproductive care

    How do doctors make decisions on Hepatitis-C treatment?

    Copyright © 2021 All rights reserved. Sitemap